Moss-FH

N/A

Report date: 2025/03/20 14:55:34

Base Information

Drug NameMoss-FH
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionComplement factor H stimulants
TargetsComplement factor H
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Hemolytic-Uremic SyndromeGlomerulonephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGreenovation Biotech Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesGreenovation Biotech Gmbh
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Hemolytic-Uremic SyndromeGlomerulonephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A